Spiegelmer

mirror-image oligonucleotide

Noxxon Pharma develops mirror-image oligonucleotides

Interviewee/Contributer: Sven Klussmann

Organisation: Noxxon Pharma AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content